MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 71 filers reported holding MERSANA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,064,075 | +82.5% | 370,540 | +330.1% | 0.01% | +80.0% |
| Q3 2022 | $583,000 | +176.3% | 86,151 | +62.9% | 0.01% | +150.0% |
| Q1 2022 | $211,000 | -31.0% | 52,900 | +135.1% | 0.00% | -33.3% |
| Q2 2021 | $306,000 | -58.8% | 22,500 | -51.0% | 0.00% | -66.7% |
| Q1 2021 | $743,000 | -81.8% | 45,902 | -70.1% | 0.01% | -83.6% |
| Q4 2020 | $4,080,000 | +136.5% | 153,337 | +65.5% | 0.06% | +66.7% |
| Q3 2020 | $1,725,000 | -25.5% | 92,645 | -6.3% | 0.03% | +6.5% |
| Q2 2020 | $2,314,000 | +880.5% | 98,874 | +144.1% | 0.03% | +106.7% |
| Q1 2020 | $236,000 | +293.3% | 40,507 | +285.8% | 0.02% | +1400.0% |
| Q4 2019 | $60,000 | -63.6% | 10,500 | +0.5% | 0.00% | -91.7% |
| Q1 2018 | $165,000 | -66.3% | 10,447 | -70.2% | 0.01% | -76.0% |
| Q2 2017 | $489,000 | – | 35,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |